← Back to all trials
Enrolling By Invitation
NCT06472830
MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study
Conditions: Monoclonal Gammopathy of Undetermined Significance
Sex: All
Ages: 40 Years – N/A
Healthy volunteers: Yes
Enrollment: 1000
Sponsor: Mayo Clinic
Location: Mayo Clinic in Rochester Rochester Minnesota
Summary
This study is being done to screen adults for MGUS and to better understand the genetic and immune factors linked to this condition. Monoclonal gammopathy of undetermined significance or MGUS is a condition where an abnormal immune protein is found in the blood. MGUS is not cancer. In some people, it slowly develops into a blood cancer called multiple myeloma. MGUS occurs in people from all backgrounds. Researchers hope to use the information from this study to improve knowledge, early detection, and future care for everyone.
Eligibility Criteria
Inclusion Criteria:
* Adults ≥ 40 years
* Willing and able to review, understand, and provide consent before starting any study-specific procedures
* Ability to complete questionnaire(s) by themselves or with assistance
Exclusion Criteria:
* Pregnant women
Source: ClinicalTrials.gov (NCT06472830). StuddyBuddy aggregates publicly available trial information.